PHP176 - Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry: Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

Autor:	Prada, M, Bertozzi, C, Proietti, B, Urbinati, D
Zdroj:	In Value in Health November 2015 18(7):A544-A544
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect